Vedolizumab treatment outcomes in early versus late Crohn's disease

The Lancet. Gastroenterology & hepatology 2026

View at publisher

Authors: Nurulamin M Noor, Ailsa L Hart, James C. Lee, Miles Parkes

DOI: 10.1016/s2468-1253(25)00349-8

Cited by: 1

References: 5

Fields of Study & Subjects

Inflammatory Bowel Disease Biosimilars and Bioanalytical Methods Rheumatoid Arthritis Research and Therapies

References 5